The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.

The decline in TB incidence over calendar years suggests protective effects of early ART initiation. The high TB incidence within the first month of ART highlights the need for more sensitive tools such as X-ray and GeneXpert to identify patients living with HIV who have clinical and subclinical TB disease at ART initiation.